Cargando…

Inequities in Treatments and Outcomes Among Patients Hospitalized With Hypertrophic Cardiomyopathy in the United States

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is the most common heritable cardiac disease. In small studies, sociodemographic factors have been associated with disparities in septal reduction therapy, but little is known about the association of sociodemographic factors with HCM treatments and outc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Daniel Y., Waken, R. J., Fox, Daniel K., Hammond, Gmerice, Joynt Maddox, Karen E., Cresci, Sharon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382014/ https://www.ncbi.nlm.nih.gov/pubmed/37232238 http://dx.doi.org/10.1161/JAHA.122.029930

Ejemplares similares

Impact of the COVID‐19 Pandemic on Patients Without COVID‐19 With Acute Myocardial Infarction and Heart Failure
por: Fox, Daniel K., et al.
Publicado: (2022)

Persistent Inequities in Intravenous Thrombolysis for Acute Ischemic Stroke in the United States: Results from the Nationwide Inpatient Sample
por: Sun, Philip, et al.
Publicado: (2023)

Segregated Patterns of Hospital Care Delivery and Health Outcomes
por: Lin, Sunny C., et al.
Publicado: (2023)

Changes in Racial Equity Associated With Participation in the Bundled Payments for Care Improvement Advanced Program
por: Hammond, Gmerice, et al.
Publicado: (2022)

Estimating the effects of race and social vulnerability on hospital admission and mortality from COVID-19
por: Landman, Joshua M, et al.
Publicado: (2021)

Care Disruption During COVID-19: a National Survey of Hospital Leaders
por: Huggins, Ashley, et al.
Publicado: (2023)

Recurrent Takotsubo Cardiomyopathy in a Patient With Hypertrophic Cardiomyopathy Leading to Cardiogenic Shock Requiring VA-ECMO
por: Husaini, Mustafa, et al.
Publicado: (2020)

Characteristics of U.S. Acute Care Hospitals That Have Implemented Telemedicine Critical Care
por: Ofoma, Uchenna R., et al.
Publicado: (2021)

Cardiac transplantation for hypertrophic cardiomyopathy in the United States 2003–2011
por: Vallabhaneni, Srilakshmi, et al.
Publicado: (2020)

Hospital revisits within 30 days after discharge for medical conditions targeted by the Hospital Readmissions Reduction Program in the United States: national retrospective analysis
por: Wadhera, Rishi K, et al.
Publicado: (2019)

Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V., et al.
Publicado: (2021)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Political environment and mortality rates in the United States, 2001-19: population based cross sectional analysis
por: Warraich, Haider J, et al.
Publicado: (2022)

Medicaid Expansion and In-Hospital Cardiovascular Mortality Failure or Unrealistic Expectations?
por: Wadhera, Rishi K., et al.
Publicado: (2018)

Is duration of hospital participation in meaningful use associated with value in Medicare?
por: Brice, Yanick N, et al.
Publicado: (2019)

In-Hospital Outcomes of Acute Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy
por: Sun, Daokun, et al.
Publicado: (2022)

The COVID-19 Pandemic and Associated Inequities in Acute Myocardial Infarction Treatment and Outcomes
por: Glance, Laurent G., et al.
Publicado: (2023)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy
por: Marston, Nicholas A, et al.
Publicado: (2021)

Reducing Cardiovascular Maternal Mortality by Extending Medicaid for Postpartum Women
por: Luther, Janki P., et al.
Publicado: (2021)

Characteristics and Outcomes of Elderly Patients With Hypertrophic Cardiomyopathy
por: Alashi, Alaa, et al.
Publicado: (2021)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

Apical Hypertrophic Cardiomyopathy: A Case Report
por: Abugroun, Ashraf, et al.
Publicado: (2017)

MT-CYB mutations in hypertrophic cardiomyopathy
por: Hagen, Christian M, et al.
Publicado: (2013)

MT-CYB mutations in hypertrophic cardiomyopathy
por: Hagen, Christian M, et al.
Publicado: (2013)

State-of-the-Art Treatments for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
por: Penela, Diego, et al.
Publicado: (2021)

The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance
por: Noureldin, Radwa A, et al.
Publicado: (2012)

An Unusual Type of Hypertrophic Cardiomyopathy
por: Seo, Hye-Sun, et al.
Publicado: (2009)

Recent advances in hypertrophic cardiomyopathy
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Diagnosis and management of hypertrophic cardiomyopathy
por: Pantazis, Antonis, et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy: A Review
por: Houston, Brian A, et al.
Publicado: (2015)

Aortic biomechanics in hypertrophic cardiomyopathy
por: Badran, Hala Mahfouz, et al.
Publicado: (2015)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)

Neuromuscular diseases with hypertrophic cardiomyopathy
por: Cesar, Sergi
Publicado: (2018)

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

The systolic paradox in hypertrophic cardiomyopathy
por: Haland, Trine F, et al.
Publicado: (2017)

ECHOCARDIOGRAPHY FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
por: Irpachi, Kalpna, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_budf8o3kcp5ata43vhs5f0ogvb